XOMA Corporation is a biotech company specializing in the discovery and development of monoclonal antibody therapeutics. With a focus on leveraging its proprietary antibody discovery technologies, XOMA offers a diversified portfolio of therapeutic candidates targeting various diseases, including cancer, metabolic disorders, and rare diseases. The company’s innovative approach and robust pipeline make it a promising player in the biotech industry.
